Works Cited

1. Abbott Diagnostics. Hepatitis Learning Guide. Abbott Park, IL: Abbott Diagnostics Educational Services; 1999.

2. Swetha Samji N. Viral Hepatitis. Available at https://emedicine.medscape.com/article/775507-overview. Last accessed January 19, 2021.

3. Bennett NJ. Pediatric Hepatitis C Clinical Presentation. Available at https://emedicine.medscape.com/article/964761-clinical. Last accessed February 11, 2020.

4. Bickley LS. Bates' Guide to Physical Examination and History Taking. 12th ed. Philadelphia, PA: Lippincott; 2016.

5. Dhawan DK. Hepatitis C. Available at https://emedicine.medscape.com/article/177792-overview. Last accessed February 11, 2021.

6. Canadian Liver Foundation. Liver Disease in Pregnancy. Available at https://www.liver.ca/patients-caregivers/liver-diseases/liver-disease-in-pregnancy/. Last accessed February 11, 2021.

7. Gewirtzman A, Bobrick L, Conner K, Tyring SK. Epidemiology of sexually transmitted infections. In: Gross G, Tyring SK (eds). Sexually Transmitted Infections and Sexually Transmitted Diseases. Berlin: Springer; 2011.

8. Centers for Disease Control and Prevention. Hepatitis C FAQs for Health Professionals. Available at https://www.cdc.gov/hepatitis/HCV/HCVfaq.htm. Last accessed February 11, 2020.

9. Centers for Disease Control and Prevention. Viral Hepatitis Surveillance Report 2018—Hepatitis A. Available at https://www.cdc.gov/hepatitis/statistics/2018surveillance/HepA.htm. Last accessed January 19, 2021.

10. Centers for Disease Control and Prevention. Hepatitis B Questions and Answers for Health Professionals. Available at https://www.cdc.gov/hepatitis/hbv/hbvfaq.htm. Last accessed February 10, 2021.

11. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR. 1998;47(RR19):1-39.

12. Centers for Disease Control and Prevention. Hepatitis B: FAQs for Healthcare Professionals. Available at https://www.cdc.gov/hepatitis/HBV/HBVfaq.htm. Last accessed January 21, 2021.

13. Redfield RR, Schuchat A, Richards CL, et al. Prevention of hepatitis A virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices, 2020. MMWR. 2020;69(5):1-38.

14. Chung RT, Dienstag JL. Liver transplantation. In: Fauci AS, Braunwals E, Isselbacher K, Wilson J, Martin J, Kasper DL, Hauser SL, Longo D (eds). Harrison's Principles of Internal Medicine. 19th ed. New York, NY: McGraw-Hill; 2015.

15. Cox R. Hepatitis C (Hep C, HCV). Available at https://www.emedicinehealth.com/hepatitis_c/article_em.htm. Last accessed February 15, 2021.

16. Strader DB. Coinfection with HIV and hepatitis C virus in injection drug users and minority populations. Clin Infect Dis. 2005;41(1):S7-S13.

17. Fong TLD. Update on Hepatitis C Treatment. Available at https://www.medscape.com/viewarticle/407963. Last accessed February 12, 2021.

18. MedlinePlus. ALP Isoenzyme Test. Available at https://medlineplus.gov/ency/article/003497.htm. Last accessed January 19, 2021.

19. Hall JE (ed). Guyton and Hall Textbook of Medical Physiology. 14th ed. Philadelphia, PA: Saunders; 2020.

20. Petta S, Craxi A. Current and future HCV therapy: do we still need other anti-HCV drugs? Liver Internat. 2015;35:4-10.

21. Nabili ST. Liver Blood Tests Levels and Results. Available at https://www.emedicinehealth.com/liver_blood_tests/article_em.htm. Last accessed January 19, 2021.

22. Dienstag JL, Delemos AS. Viral hepatitis. In: Bennett JE, Dolin R, Blaser MJ (eds). Mandell, Douglas and Bennett's Infectious Disease Essentials. 1st ed. Philadelphia, PA: Elsevier; 2016: 130-137.

23. Lucey MR. New Trends in Liver Transplantation. Conference Summary, the American Association for the Study of Liver Diseases 50th Annual Meeting. Dallas, TX. November 5–9, 1999.

24. Evans AA, Cohen C, Block TM. Hepatitis viruses: hepatitis B and hepatitis D. In: Kaslow RA, Stanberry LR, LeDuc JW (eds). Viral Infections of Humans: Epidemiology and Control. 5th ed. New York, NY: Springer; 2014: 747-764.

25. Marx JF. ABCDE&G: understanding the varieties of viral hepatitis. Nursing. 1998;28:43-49.

26. Alberti A, Benvegnù L. Viral infections of the liver. In: Rodés J, Benhamou JP, Blei A, REichen J, Rizzetto M(eds). Textbook of Hepatology: From Basic Science to Clinical Practice. 3rd ed. Oxford: Blackwell Publishing; 2007.

27. Thio CL, Hawkins C. Hepatitis B virus and hepatitis delta virus. In: Bennett JE, Dolin R, Blaser MJ (eds). Mandell, Douglas and Bennett's Infectious Disease Essentials. 1st ed. Philadelphia, PA: Elsevier; 2016: 198-201.

28. Rosen HR, Martin P. Hepatitis B and C in the liver transplant recipient. Semin Liver Dis. 2000;20:465-480.

29. Illinois Department of Public Health. Hepatitis B. Available at http://www.idph.state.il.us/public/hb/hbhepb.htm. Last accessed January 21, 2021.

30. Lab Tests Online. Hepatitis C Testing. Available at https://labtestsonline.org/tests/hepatitis-c-testing. Last accessed February 15, 2021.

31. Luu L. Liver Transplants. Available at https://emedicine.medscape.com/article/776313-overview. Last accessed January 21, 2020.

32. Heuft HG, Berg T, Schreier E, et al. Epidemiological and clinical aspects of hepatitis G virus infection in blood donors and immunocompromised recipients of HGV-contaminated blood. Vox Sanguinis. 1998;74:161-167.

33. Sherman M. Management of viral hepatitis: clinical and public health perspectives—a consensus statement. Can J Gastroenterol. 1997;11(5):407-416.

34. Contag SA. Hepatitis in Pregnancy. Available at https://emedicine.medscape.com/article/1562368-overview. Last accessed January 19, 2021.

35. Lin YN, Chou JW, Cheng KS, Peng CY, Jeng LB, Chiang IP. Treatment of fulminant autoimmune hepatitis: corticosteroid therapy or liver transplantation? A case report and literature review. Gastroenterology Res. 2011;4(5):231-235.

36. Tepper ML, Gully PR. Viral hepatitis: know your D, E, F, and G. Can Med Assoc J. 1997;156:1735-1738.

37. Sood GK. Acute Liver Failure. Available at https://emedicine.medscape.com/article/177354-overview. Last accessed January 21, 2021.

38. Bennett JE, Dolin R, Blaser MJ (eds). Mandell, Douglas and Bennett's Infectious Disease Essentials. 1st ed. Philadelphia, PA: Elsevier; 2016.

39. Murali AR, Carey WD. Approach to the Patient with Liver Disease: A Guide to Commonly Used Liver Tests. Available at http://www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/hepatology/guide-to-common-liver-tests. Last accessed January 19, 2020.

40. World Health Organization. Immunizations, Vaccines and Biologicals: Hepatitis A. Available at https://www.who.int/immunization/diseases/hepatitisA/en/. Last accessed January 19, 2020.

41. Centers for Disease Control and Prevention. Disease Burden from Hepatitis A, B, and C in the United States. Available at https://www.cdc.gov/hepatitis/PDFs/disease_burden.pdf. Last accessed January 19, 2021.

42. Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. 13th ed. Washington, DC: Public Health Foundation; 2015.

43. World Health Organization. Immunization, Vaccines and Biologicals: Hepatitis E. Available at https://www.who.int/immunization/diseases/hepatitisE/en/. Last accessed January 19, 2021.

44. World Health Organization. Hepatitis B. Available at https://www.who.int/news-room/fact-sheets/detail/hepatitis-b. Last accessed February 15, 2021.

45. U.S. Department of Veterans Affairs. Chronic Hepatitis C Virus (HCV) Infection: Treatment Considerations. Available at https://www.hepatitis.va.gov/hcv/treatment/hcv-treatment-considerations.asp. Last accessed February 12, 2021.

46. Hanto DW. A 50-year-old man with hepatitis C and cirrhosis needing liver transplantation. JAMA. 2003;290(24):3238-3246.

47. Swetha Samji N. Viral Hepatitis Clinical Presentation. Available at https://emedicine.medscape.com/article/775507-clinical. Last accessed February 15, 2021.

48. Chan C, Fan ST, Lo CM, et al. A decade of right liver adult-to-adult living donor liver transplantation: the recipient mid-term outcomes. Ann Surg. 2008:248(3):411-419.

49. Paul N, Han SH. Combination therapy for chronic hepatitis B: current indications. Curr Hepat Rep. 2011;10(2):98-105.

50. Bernardi M, Gitto S, Biselli M. The MELD score in patients awaiting liver transplant: strengths and weaknesses. J Hepatol. 2011;54(6):1297-1306.

51. U.S. Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. Available at https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/AdultandAdolescentGL.pdf. Last accessed February 10, 2021.

52. U.S. Preventive Services Task Force. Screening for hepatitis C virus infection in adolescents and adults: U.S. Preventive Services Task Force recommendation statement. JAMA. 2020;323(10):970-975.

53. Hertl F, Markhamann JF, Russell S, Yeh H. Liver transplantation. In: Merck Manual Professional. Available at http://www.merckmanuals.com/professional/immunology_allergic_disorders/transplantation/liver_transplantation.html. Last accessed February 15, 2021.

54. Wedemyer H, Yurdaydìn C, Dalekos GN, et al. Peginterferon plus adefovir versus drug alone for hepatitis delta. N Engl J Med. 2011;364(4):322-331.

55. Soriano V, Barreiro P, Cachay E, et al. Advances in hepatitis B therapeutics. Ther Adv Infectious Dis. 2020;7:1-11.

56. Goldsmith C. Hepatitis. Minneapolis, MN: Twenty-First Century Books; 2011.

57. LexiComp Online. Available at https://online.lexi.com. Last accessed February 10, 2021.

58. American Liver Foundation. Liver Transplant. Available at https://liverfoundation.org/for-patients/about-the-liver/liver-transplant. Last accessed February 15, 2021.

59. Ly KN, Xing J, Klevens RM, Jiles RB, Ward JW, Holmberg SD. The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Ann Intern Med. 2012;156(4):271-278.

60. Hoofnagle J, Sherker A. Therapy for hepatitis C: the cost of success. N Engl J Med. 2014;370:1552-1553.

61. U.S. Food and Drug Administration. FDA Approves New Treatment for Hepatitis C Virus. Available at http://www.idsociety.org/FDA_approves_new_treatment_for_hepatitis_C_virus.aspx. Last accessed February 14, 2018.

62. U.S. Food and Drug Administration. Drug Approval Package: Sovaldi. Available at https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/212480Orig1s000TOC.cfm. Last accessed February 15, 2021.

63. Centers for Disease Control and Prevention. Hepatitis C Tables and Figures. Available at https://www.cdc.gov/hepatitis/statistics/2018surveillance/TablesFigures-HepC.htm. Last accessed February 11, 2021.

64. Kohli A, Shaffer A, Sherman A, Kottilil S. Treatment of hepatitis C: a systematic review. JAMA. 2014;312(6):631-640.

65. U.S. Food and Drug Administration. FDA Approves New Treatment for Chronic Hepatitis C Genotype 3 Infections. Available at https://wayback.archive-it.org/7993/20170112023754/http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm455888.htm. Last accessed February 15, 2021.

66. Wyles DL, Ruane PJ, Sulkowski MS, et al. Daclatasvir plus sofosbuvir for HCV in patients coinfected with HIV-1. JAMA. 2015;373:714-725.

67. U.S. Food and Drug Administration. FDA Approves Technivie for Treatment of Chronic Hepatitis C Genotype 4. Available at https://wayback.archive-it.org/7993/20170112222743/http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm455857.htm. Last accessed February 15, 2021.

68. Centers for Disease Control and Prevention. CDC Urging Dialysis Providers and Facilities to Assess and Improve Infection Control Practices to Stop Hepatitis C Virus Transmission in Patients Undergoing Hemodialysis. Available at https://emergency.cdc.gov/han/han00386.asp. Last accessed February 11, 2021.

69. Infectious Disease Society of America, and American Association for the Study of Liver Diseases. HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C. Available at https://www.hcvguidelines.org. Accessed February 10, 2021.

70. Centers for Disease Control and Prevention. Viral Hepatitis Serology Training. Available at https://www.cdc.gov/hepatitis/resources/professionals/training/serology/training.htm. Last accessed January 21, 2021.

71. U.S. Food and Drug Administration. FDA Approves New Treatment for Pediatric Patients with Any Strain of Hepatitis C. Available at https://www.fda.gov/news-events/press-announcements/fda-approves-new-treatment-pediatric-patients-any-strain-hepatitis-c. Last accessed February 15, 2021.

72. Centers for Disease Control and Prevention. Hepatitis C Mortality. Available at https://www.cdc.gov/nchhstp/newsroom/2016/hcv-mortality.html Last accessed February 11, 2021.

73. Hedskog C, Parhy B, Chang S, et al. Identification of 19 novel hepatitis C virus subtypes: further expanding HCV classification. Open Forum Infect Dis. 2019;6(3):ofz076.

74. U.S. Food and Drug Administration. FDA Approves Mavyret for Hepatitis C. Available at https://www.fda.gov/news-events/press-announcements/fda-approves-mavyret-hepatitis-c. Last accessed February 15, 2021.

75. Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 Hepatitis B Guidance. Hepatology. 2018;67(4):1560-1599.

76. Nemergut K, Littlewood EC. Liver diseases. In: Fleisher LA (ed). Anesthesia and Uncommon Diseases. 6th ed. Philadelphia, PA: Saunders, 2012; 151-202.

77. Bhattarai N, Stapleton, JT. GB virus C: the good boy virus? Trends Microbiol. 2012;20(3):124-130.

78. Poynard T, Bedossa P, Opolon, P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet. 1997;349(9055):825-832.

79. Lim SG, Ng TM, Kung N, et al. A double-blind placebo-controlled study of emtricitabine in chronic hepatitis B. Arch Intern Med. 2006;166(1):49-56.

80. Technical Bulletin: PURELL Healthcare Surface Disinfectant. Available at https://cdn2.hubspot.net/hubfs/43298/PURELL%20Healthcare%20Surface%20Disinfectant%20Technical%20Bulletin.pdf . Last accessed March 15, 2021.

81. The Hepatitis Trust. Razors and toothbrushes. Available at http://www.hepctrust.org.uk/information/risk-factors/razors-and-toothbrushes. Last accessed March 15, 2021.

Evidence-Based Practice Recommendations Citations

1. U.S. Preventive Services Task Force. Screening for Hepatitis B Virus Infection in Adolescents and Adults. Available at https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-b-virus-infection-screening. Last accessed February 22, 2021.

2. Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):261-283. Available at https://www.aasld.org/sites/default/files/2019-06/HBVGuidance_Terrault_et_al-2018-Hepatology.pdf. Last accessed February 22, 2021.

3. U.S. Preventive Services Task Force. Hepatitis C Virus Infection in Adolescents and Adults: Screening. Available at https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-c-screening. Last accessed February 22, 2021.


Copyright © 2021 NetCE, P.O. Box 997571, Sacramento, CA 95899-7571
Mention of commercial products does not indicate endorsement.